Literature DB >> 12770934

Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum.

Ming-Jen Hsu1, Shiuh-Sheng Lee, Sho Tone Lee, Wan-Wan Lin.   

Abstract

1 The polysaccharide from Ganoderma lucidum (PS-G) has been reported to enhance immune responses and to elicit antitumor effects. In our previous study, we found that PS-G efficiently inhibited spontaneously and Fas-enhanced neutrophil apoptosis when cultured in vitro. Since phagocytosis and chemotaxis play essential roles in host defense mediated by neutrophils, it is of great interest to know the effect of PS-G on these two cell functions, and the molecular events leading to these actions. 2 Using latex beads and heat-inactive Escherichia coli serving as particles for neutrophil engulfment, we found that PS-G is able to enhance phagocytic activity of human primary neutrophils and neutrophilic-phenotype cells differentiated from all trans retinoic acid-treated HL-60 cells. 3 Chemotactic assay using Boyden chamber also revealed the ability of PS-G to increase neutrophil migration. 4 Exposure of neutrophils to PS-G time dependently caused increases in protein kinase C (PKC), p38 mitogen-activated protein kinase (MAPK), Hck, and Lyn activities. 5 Results with specific kinase inhibitors indicate that phagocytic action of PS-G was reduced by the presence of wortmannin (Phosphatidylinositol 3-kinase, PI3K inhibitor), pyrazolpyrimidine 2 (Src-family tyrosine kinase inhibitor), Ro318220 (PKC inhibitor), and SB203580 (p38 MAPK inhibitor), but not by PD98059 (mitogen-activated protein/ERK kinase inhibitor). Moreover, chemotactic action of PS-G requires the activities of PI3K, p38 MAPK, Src tyrosine kinases and PKC. 6 All these results demonstrate the abilities of PS-G to enhance neutrophil function in phagocytosis and chemotaxis, and further provide evidence to strengthen the beneficial remedy of G. lucidum in human to enhance defense system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770934      PMCID: PMC1573843          DOI: 10.1038/sj.bjp.0705243

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

Review 1.  Macrophage lectins in host defence.

Authors:  S A Linehan; L Martínez-Pomares; S Gordon
Journal:  Microbes Infect       Date:  2000-03       Impact factor: 2.700

2.  Opsonized zymosan stimulates the redistribution of protein kinase C isoforms in human neutrophils.

Authors:  S Sergeant; L C McPhail
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

3.  Lyn and Fgr are activated in distinct membrane fractions of human granulocytic cells.

Authors:  H Welch; I Maridonneau-Parini
Journal:  Oncogene       Date:  1997-10-23       Impact factor: 9.867

4.  C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement.

Authors:  R M Heuertz; S M Tricomi; U R Ezekiel; R O Webster
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes.

Authors:  T Yamamori; O Inanami; H Nagahata; Y Cui; M Kuwabara
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

6.  PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor.

Authors:  E Wakshull; D Brunke-Reese; J Lindermuth; L Fisette; R S Nathans; J J Crowley; J C Tufts; J Zimmerman; W Mackin; D S Adams
Journal:  Immunopharmacology       Date:  1999-02

7.  Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways.

Authors:  J B Klein; M J Rane; J A Scherzer; P Y Coxon; R Kettritz; J M Mathiesen; A Buridi; K R McLeish
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

8.  The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.

Authors:  Y Xia; V Vetvicka; J Yan; M Hanikýrová; T Mayadas; G D Ross
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

9.  Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.

Authors:  T Kodama; K Hazeki; O Hazeki; T Okada; M Ui
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

10.  Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity.

Authors:  J Liang; D Melican; L Cafro; G Palace; L Fisette; R Armstrong; M L Patchen
Journal:  Int J Immunopharmacol       Date:  1998-11
View more
  16 in total

1.  Identification of phosphoproteins associated with human neutrophil granules following chemotactic peptide stimulation.

Authors:  Gregory C Luerman; David W Powell; Silvia M Uriarte; Timothy D Cummins; Michael L Merchant; Richard A Ward; Kenneth R McLeish
Journal:  Mol Cell Proteomics       Date:  2010-11-19       Impact factor: 5.911

2.  Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages.

Authors:  Connie W H Woo; Ricky Y K Man; Yaw L Siow; Patrick C Choy; Eric W Y Wan; Chak S Lau; Karmin O
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

3.  Management of Combined Therapy (Ceritinib, A. cinnamomea, G. lucidum, and Photobiomodulation) in Advanced Non-Small-Cell Lung Cancer: A Case Report.

Authors:  Chuan-Tsung Su; Jih-Huah Wu
Journal:  Life (Basel)       Date:  2022-06-09

4.  Regulation of neutrophil function by selective targeting of glycan epitopes expressed on the integrin CD11b/CD18.

Authors:  Matthias Kelm; Sylvain Lehoux; Veronica Azcutia; Richard D Cummings; Asma Nusrat; Charles A Parkos; Jennifer C Brazil
Journal:  FASEB J       Date:  2019-12-23       Impact factor: 5.191

5.  Fractionation and characterization of biologically-active polysaccharides from Artemisia tripartita.

Authors:  Gang Xie; Igor A Schepetkin; Daniel W Siemsen; Liliya N Kirpotina; James A Wiley; Mark T Quinn
Journal:  Phytochemistry       Date:  2008-03-05       Impact factor: 4.072

6.  Antitumor and Immunomodulatory Effects of Polysaccharides from Broken-Spore of Ganoderma lucidum.

Authors:  Peng-Yun Wang; Xiao-Ling Zhu; Zhi-Bin Lin
Journal:  Front Pharmacol       Date:  2012-07-13       Impact factor: 5.810

Review 7.  Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus.

Authors:  Yuxi Guo; Xuefeng Chen; Pin Gong
Journal:  Int J Biol Macromol       Date:  2021-05-25       Impact factor: 8.025

8.  Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors.

Authors:  Cheng-Li Wang; Chiu-Ying Lu; Chia-Chen Pi; Yu-Jing Zhuang; Ching-Liang Chu; Wen-Hsiung Liu; Chun-Jen Chen
Journal:  BMC Complement Altern Med       Date:  2012-08-10       Impact factor: 3.659

9.  Jungle honey enhances immune function and antitumor activity.

Authors:  Miki Fukuda; Kengo Kobayashi; Yuriko Hirono; Mayuko Miyagawa; Takahiro Ishida; Emenike C Ejiogu; Masaharu Sawai; Kent E Pinkerton; Minoru Takeuchi
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

10.  The multifaceted effects of polysaccharides isolated from Dendrobium huoshanense on immune functions with the induction of interleukin-1 receptor antagonist (IL-1ra) in monocytes.

Authors:  Juway Lin; Ya-Jen Chang; Wen-Bin Yang; Alice L Yu; Chi-Huey Wong
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.